Doxycycline is indicated for the treatment of bacterial infections, such as urinary tract infections, acne, gonorrhea, chlamydia, periodontitis and others.
Arthur Bedrosian, president and CEO of Lannett, said: “The approvals of doxycycline tablets, 75mg and 150mg, round out our doxycycline portfolio, supplementing our 50mg and 100mg dosages. We will commence marketing our doxycycline tablets, 75mg and 150mg, immediately.”